Acerus Announces Closing Of Acquisition Of Serenity Pharmaceuticals Llc And Acquisition Of Global Rights To Noctiva™
Acquiring Company
Acerus
Acquired Company
Serenity
DenverBiotechnologySoftwareHealth Careinformation technology & servicesDescription
Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced the closing of its previously-announced acquisition of Serenity Pharmaceuticals LLC (“Serenity”), including the global rights to its NoctivaTM brand. Serenity, based in Miami, FL, is a specialty pharmaceutical company focused on developing therapies for diseases associated with voiding disorders and had previously been granted approval by the U.S. Food and Drug Administration (FDA) for its NoctivaTM (desmopressin acetate) nasal spray. Additional details of this transaction can be found in the Company’s filings in the US and Canada.
Quick answer
Acerus is acquiring Serenity, announced March 7, 2022.
- How much did Acerus pay for Serenity?
- The deal value was not disclosed.
- What does Acerus do?
- Acerus Pharmaceuticals Corporation is a specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus in the..
- Where are Acerus and Serenity based?
- Serenity is based in Denver, Colorado, United States.
Source: Fundz verified event record.
Other recent acquisitions in information technology & services and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Hikma Completes Acquisition Of Custopharm (April 21, 2022)
- Consegna Pharma Acquires Fathom Pharma To Strengthen Initiatives That Address The Opioid Crisis (April 19, 2022)
- Regeneron To Acquire Checkmate Pharmaceuticals And Its Investigational Immune Activator For Potential Use In Multiple Tumor Types (April 19, 2022)
- Halozyme To Acquire Antares Pharma To Create A Specialty Product And Drug Delivery Leader (April 13, 2022)
- Masimo Closes Acquisition Of Sound United (April 12, 2022)
- Acerus Announces Definitive Agreement To Acquire Serenity Llc And The Global Rights To Noctiva™ (February 28, 2022)
Who to call at Acerus, and when
When Acerus changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Acerus raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Acerus, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Acerus. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Acerus makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Serenity?
Serenity was acquired by Acerus. The deal was reported on March 7, 2022. Acerus is privately held.
When did Acerus acquire Serenity?
Acerus's acquisition of Serenity was reported on March 7, 2022. Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced the closing of its previously-announced acquisition of Serenity Pharmaceuticals LLC (“Serenity”), including the global rights to its NoctivaTM brand. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Serenity do?
It is privately held, operating in Biotechnology, and is based in Denver.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.